Advanced company searchLink opens in new window

CENTRAL PHARMA CONTRACT HOLDINGS LIMITED

Company number 08126719

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 Jan 2024 CS01 Confirmation statement made on 4 January 2024 with no updates
15 Jan 2024 RP04CS01 Second filing of Confirmation Statement dated 4 January 2023
27 Dec 2023 SH01 Statement of capital following an allotment of shares on 28 December 2022
  • GBP 272,738.89
26 Oct 2023 AA Group of companies' accounts made up to 31 December 2022
20 Jul 2023 AA Group of companies' accounts made up to 31 December 2021
07 Jun 2023 DISS40 Compulsory strike-off action has been discontinued
16 May 2023 DISS16(SOAS) Compulsory strike-off action has been suspended
11 Apr 2023 GAZ1 First Gazette notice for compulsory strike-off
26 Jan 2023 CS01 Confirmation statement made on 4 January 2023 with no updates
  • ANNOTATION Clarification a second filed CS01 (Statement of Capital, Shareholder information) was registered on 15/01/2024
30 Aug 2022 CS01 Confirmation statement made on 2 July 2022 with no updates
01 Apr 2022 TM01 Termination of appointment of Amanda Bently as a director on 31 December 2021
09 Dec 2021 AA Group of companies' accounts made up to 31 December 2020
31 Jul 2021 CS01 Confirmation statement made on 2 July 2021 with updates
23 Dec 2020 AA Group of companies' accounts made up to 31 December 2019
05 Oct 2020 MA Memorandum and Articles of Association
05 Oct 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Transfer of 40,423 a ordinary shares of £1.00 each 12/06/2020
  • RES01 ‐ Resolution of alteration of Articles of Association
25 Sep 2020 CS01 Confirmation statement made on 2 July 2020 with updates
25 Sep 2020 AP01 Appointment of Mr Michael James Blood as a director on 12 June 2020
25 Sep 2020 PSC01 Notification of Michael James Blood as a person with significant control on 31 August 2018
24 Sep 2020 PSC07 Cessation of Ronald Michael Hene as a person with significant control on 31 August 2018
24 Sep 2020 SH01 Statement of capital following an allotment of shares on 12 June 2020
  • GBP 140,753.89
03 Dec 2019 AP01 Appointment of Mrs Karen Yvonne Nichol as a director on 1 November 2019
02 Sep 2019 AA Group of companies' accounts made up to 31 December 2018
02 Jul 2019 CS01 Confirmation statement made on 2 July 2019 with no updates
07 Jan 2019 TM01 Termination of appointment of Ronald Michael Hene as a director on 31 August 2018